Suchergebnisse - %22Macrophage activation syndrome%22

PubPharm (8)

1

Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm : Case series of four critically ill patients treated with leronlimab

enthalten in: Journal of translational autoimmunity | 2021

von Agresti, N. | Lalezari, J. | Amodeo, P. | +14

2

Pathology of macrophage activation syndrome in humanized NSGS mice

enthalten in: Research in veterinary science | 2021

von Tarrant, J. | Binder, Z. | Bugatti, M. | +9

3

Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome

enthalten in: Molecular cancer | 2021

von Wei, Y. | Li, C. | Bian, H. | +6

4

Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells

enthalten in: Cellular microbiology | 2020

von Lee, K. | Lee, J. | Lee, P. | +6

5

Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation

enthalten in: Rheumatology (Oxford, England) | 2020

von Jørgensen, S. | Christiansen, M. | Høst, C. | +7

6

Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-κB activation

enthalten in: Journal of applied toxicology : JAT | 2018

von Osabe, M. | Tajika, T. | Tohkin, M.

7

Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome

enthalten in: Frontiers in immunology | 2018

von Barsalou, J. | Blincoe, A. | Fernandez, I. | +6

8

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases

enthalten in: Autoimmunity reviews | 2014

von Antonelli, A. | Ferrari, S. | Giuggioli, D. | +3

1
[1]